Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) PT at $38.18

Bath & Body Works, Inc. (NYSE:BBWI) has earned a consensus rating of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $38.1786.

Several brokerages have recently commented on BBWI. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $26.00 target price on shares of Bath & Body Works in a report on Monday, October 6th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday, August 28th. Barclays decreased their target price on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a report on Monday, October 20th. UBS Group cut their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Finally, Citigroup decreased their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a research note on Tuesday, August 19th.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $21.93 on Friday. The firm has a market cap of $4.52 billion, a price-to-earnings ratio of 6.51, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. Bath & Body Works has a 1 year low of $21.82 and a 1 year high of $41.87. The firm’s 50 day moving average price is $26.01 and its two-hundred day moving average price is $28.70.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Victory Capital Management Inc. grew its stake in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after acquiring an additional 6,752,274 shares in the last quarter. Jupiter Asset Management Ltd. lifted its holdings in shares of Bath & Body Works by 553.2% during the 3rd quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after buying an additional 3,145,797 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Bath & Body Works by 267.8% during the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after buying an additional 2,907,506 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its stake in shares of Bath & Body Works by 115.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after buying an additional 1,973,679 shares in the last quarter. Finally, Norges Bank acquired a new position in Bath & Body Works in the second quarter worth approximately $57,746,000. 95.14% of the stock is owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.